Mobile phone related articles are
Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Endpoints | Frequency range | SAR | Exposure duration | Parameters |
---|---|---|---|---|---|---|---|
Adey WR et al. | 1999 | animal, rat/Fischer 344, whole body, partial body: head | CNS tumors | 836.55 MHz | 1–1.4 W/kg | continuous for about 25 days, see add. information | NADC, TDMA, mobile communications, microwaves |
Adey WR et al. | 2000 | animal, rat/Fischer 344, whole body, partial body: head | CNS tumors | 836.55 MHz | 0.27–1.2 W/kg | continuous for about 25 days, see add. information | mobile communications, mobile phone, microwaves |
Akhavan-Sigari R et al. | 2014 | human, partial body: head | relationship between <i>p53</i> expression, <i>p53</i> mutations, survival time and cell phone usage | 800–1,900 MHz | 0.66–1.53 W/kg | repeated daily exposure of less than 3 hours | mobile phone, mobile communications |
Anane R et al. | 2003 | animal, rat/Sprague-Dawley, whole body | mammary gland tumors | 900 MHz | 0.1–3.5 W/kg | repeated daily exposure, 2 h/day, 5 days/week for 9 weeks | GSM, mobile communications, microwaves |
Anderson LE et al. | 2004 | animal, rat/Fischer 344, whole body, partial body: head (from day 35 of age through 2 years) | cancer | 1.62 GHz | 0.06–1.6 W/kg | repeated daily exposure, 2 h/day, for about 27 days | mobile communications, IRIDIUM |
Anghileri LJ et al. | 2005 | animal, mouse/CF1 (Ico:OFI), whole body | carcinogenesis | 800 MHz | - | repeated exposure for 1 hour per week for 4 months | mobile communications, mobile phone |
Anghileri LJ et al. | 2006 | animal, mouse/Ico OFI, whole body | - | 800 MHz | - | - | mobile phone, mobile communications, RF field, co-exposure |
Anghileri LJ et al. | 2006 | animal, mouse/Ico OFI | - | 800 MHz | - | - | mobile communications, mobile phone, also other exposures without EMF |
Bartsch H et al. | 2002 | animal, rat/Sprague-Dawley, whole body | mammary tumors | 900 MHz | 60–130 mW/kg | nearly continuous until the largest tumour reached a diameter of 1-2 cm | GSM, mobile communications |
Bastide M et al. | 2001 | animal, chicken embryos (eggs) and chicks, mouse/C57BL/6 j RJ, whole body | cancer in mice, hormone levels in chicken and mice, antibody levels in chicken, mortality in chicken embryos | 900 MHz | - | continuous for up to 15 weeks | mobile phone, GSM, mobile communications, magnetic field, low frequency, 50/60 Hz, PC/TV monitor, shielding/field deprivation |
Brooks AM et al. | 2024 | animal, rat/Sprague-Dawley | - | 1.8 GHz | - | - | mobile communications, mobile phone base station, GSM, RF field |
Chagnaud JL et al. | 1999 | animal, rat/Sprague-Dawley, whole body | cancer | 900 MHz | 75–270 mW/kg | repeated daily exposure, 2 h/day, 5 days/week for 2 weeks | mobile communications, GSM, low level microwaves |
Falcioni L et al. | 2018 | animal, rat/Sprague Dawley, whole body | brain and heart tumors | 1,835 MHz | 0.001–0.1 W/kg | 19 h/day, 7 days/week from 12th day of gestation until natural death (up to 152 weeks) | mobile communications, mobile phone base station, GSM |
Heikkinen P et al. | 2001 | animal, mouse/CBA/s, whole body | tumor development | 902.4 MHz | 0.35–1.5 W/kg | repeated daily exposure, 1.5 h/day, 5 days a week for 78 weeks | analog mobile phone, digital mobile phone, GSM, NMT, mobile communications |
Heikkinen P et al. | 2003 | animal, mouse/transgenic of the line K2 (over-expressing the human ODC gene) and non-transgenic littermate, whole body | skin tumours | 849 MHz | 0.5–4 W/kg | repeated daily exposure for 1.5 h/day, 5 days/week for 52 weeks | digital mobile phone, GSM, D-AMPS, mobile communications |
Heikkinen P et al. | 2006 | animal, rat/Wistar, whole body | tumorigenesis; cocarcinogenic effects | 900 MHz | 0.3–0.9 W/kg | repeated daily exposure, 2 h/day, 5 days/week, for 104 weeks | digital mobile phone, GSM, mobile communications |
Higashikubo R et al. | 1999 | animal, rat/Fischer 344, implemented with different numbers of 9L gliosarcoma cells, partial body: head | brain tumor | 835.26 MHz | 0.75 W/kg | repeated daily exposure, 4 h/day, 5 days/week, for up to 178 days | mobile communications, CDMA |
Hruby R et al. | 2008 | animal, rat/Sprague-Dawley, whole body | mammary tumor | 902 MHz | 0.4–4 W/kg | repeated daily exposure, 4 h/day, 5 days/week, for 6 months | digital mobile phone, GSM, mobile communications |
Huang TQ et al. | 2005 | animal, mouse/ICR, whole body | skin tumors | 848.5 MHz | 0.4 W/kg | repeated daily exposure, 45 min on/15 min off/45 min on, 5 days/week for 19 weeks | PCS, CDMA, mobile communications |
Imaida K et al. | 1998 | animal, rat/Fischer 344, whole body | liver cancer | 1.439 GHz | 0.68–7.6 W/kg | repeated daily exposure for 90 min/day, 5 days/week, over 6 weeks | TDMA, mobile communications |
Imaida K et al. | 1998 | animal, rat/Fischer 344, whole body | liver cancer | 929.2 MHz | 0.8–72 W/kg | repeated daily exposure, 90 min/day, 5 days a week, over 6 weeks | mobile communications, PDC, TDMA |
Imaida K et al. | 2001 | animal, mouse/ICR, partial body: skin | skin tumors | 1.49 GHz | 0.084–2 W/kg | repeated daily exposure, 90 min/day, 5 days/week for 19 weeks | PDC, TDMA, mobile communications |
LaRegina MC et al. | 2003 | animal, rat/Fischer 344 | cancer | 835.62 MHz | 1.3 W/kg | repeated daily exposure, 4 h/day, 5 days/week, over two years | mobile communications, CDMA, FDMA, microwaves |
Lee HJ et al. | 2011 | animal, mouse/AKR/J, whole body | carcinogenesis (lymphoma incidence) | 848.5–1,950 MHz | 2 W/kg | continuous for 45 min/day, 5 days/week for up to 42 weeks | mobile communications, mobile phone, CDMA, W-CDMA |
Lerchl A et al. | 2015 | animal, mouse/C3H/HeNCrl x C57Bl/6N, whole body | number, size and morphology of tumors in different tissues | - | 0.04–2 W/kg | continuous for 23.3 h per day, 7 days per week, starting <i>in utero</i> up to 72 weeks | mobile phone, UMTS, mobile communications, co-exposure |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.